tiprankstipranks
Advertisement

QVMS - ETF AI Analysis

Compare

Top Page

QVMS

Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS)

Rating:67Neutral
Price Target:
QVMS, the Invesco S&P SmallCap 600 QVM Multi-factor ETF, has a solid overall rating that reflects a portfolio of generally strong small-cap companies with a mix of growth, quality, and value traits. Standout holdings like Paycom, with robust revenue growth and profitability, and Corcept Therapeutics, with strong financial health and supportive technical trends, help lift the fund’s quality, while names such as ViaSat and Element Solutions, which face profitability or bearish technical and valuation pressures, modestly weigh on the rating. The main risk factor is that several holdings show valuation concerns or leverage and cash flow challenges, which can make the fund more sensitive to market downturns.
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year, showing solid momentum in its strategy.
Well-Performing Top Holdings
Many of the largest positions, such as ViaSat, Argan, Formfactor, and Maxlinear, have shown strong year-to-date performance, helping drive the fund’s returns.
Low Expense Ratio
The fund’s relatively low fee means more of the investment returns can stay in investors’ pockets over time.
Negative Factors
Heavy U.S. Focus
With almost all assets in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. economy.
Small-Cap Risk
Because the fund targets smaller companies, it can be more volatile and sensitive to economic slowdowns than large-cap funds.
Sector Tilts
Significant weight in sectors like Financials, Industrials, and Technology means the fund could be more affected if these areas of the market weaken.

QVMS vs. SPDR S&P 500 ETF (SPY)

QVMS Summary

The Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS) invests in smaller U.S. companies and follows the S&P SmallCap 600 Quality, Value & Momentum Top 90% Multi-Factor Index. It spreads money across many sectors like financials, industrials, and technology, and holds companies such as Molina Healthcare and Eastman Chemical. Someone might invest in this ETF to seek long-term growth and diversification by owning many small, potentially fast-growing businesses in one fund. However, small-cap stocks can be more volatile than larger companies, so the ETF’s value can rise and fall sharply with the market.
How much will it cost me?The Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for actively managed funds, as it uses a multi-factor strategy to select investments while keeping costs relatively low.
What would affect this ETF?The QVMS ETF, focusing on U.S. small-cap stocks across sectors like financials, industrials, and technology, could benefit from economic growth and innovation in these industries, as well as favorable conditions for small-cap companies, such as lower interest rates or increased investor appetite for risk. However, it may face challenges from economic slowdowns, higher interest rates, or sector-specific issues like regulatory changes in healthcare or technology, which could impact its top holdings and overall performance.

QVMS Top 10 Holdings

QVMS is leaning into U.S. small caps with a mix of rising growth stories and a few names losing steam. Corcept Therapeutics and Paycom are doing much of the heavy lifting, with strong momentum that helps power the fund’s recent results. Brinker International and Glaukos add to the upside, reflecting steady consumer and health-care strength. On the other side, ViaSat and Element Solutions have been lagging, acting as mild brakes on performance. Overall, the ETF is broadly spread across sectors, with no single industry or stock dominating the show.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ViaSat0.77%$1.92M$9.28B108.38%
56
Neutral
Paycom0.76%$1.90M$10.56B5.01%
76
Outperform
Brinker International0.62%$1.55M$9.61B47.58%
70
Neutral
Corcept Therapeutics0.61%$1.52M$12.31B63.34%
76
Outperform
Jackson Financial Incorporation0.59%$1.47M$9.09B35.79%
73
Outperform
Eastman Chemical0.57%$1.42M$8.35B3.82%
72
Outperform
Glaukos0.56%$1.39M$10.61B87.72%
61
Neutral
Qorvo0.56%$1.39M$8.36B4.44%
71
Outperform
Element Solutions0.55%$1.37M$8.51B35.81%
65
Neutral
Formfactor0.54%$1.36M$7.94B248.39%
68
Neutral

QVMS Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
34.49
Negative
100DMA
33.41
Positive
200DMA
31.32
Positive
Market Momentum
MACD
-0.18
Positive
RSI
43.01
Neutral
STOCH
21.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QVMS, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 34.56, equal to the 50-day MA of 34.49, and equal to the 200-day MA of 31.32, indicating a neutral trend. The MACD of -0.18 indicates Positive momentum. The RSI at 43.01 is Neutral, neither overbought nor oversold. The STOCH value of 21.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for QVMS.

QVMS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$247.34M0.15%
67
Neutral
$855.11M0.48%
72
Outperform
$802.34M0.49%
68
Neutral
$755.95M0.09%
63
Neutral
$733.65M0.42%
68
Neutral
$725.55M0.40%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
QVMS
Invesco S&P SmallCap 600 QVM Multi-factor ETF
33.94
6.18
22.26%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
SFLO
VictoryShares Small Cap Free Cash Flow ETF
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
JHSC
John Hancock Multifactor Small Cap ETF
SMDV
ProShares Russell 2000 Dividend Growers ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement